-
PCR Biosystems, a leading developer of PCR reagents, have launched a range of advanced inhibitor-tolerant mixes for probe-based qPCR and 1-step RT-qPCR. Available in the Clara® and Air-Dryable product ranges to help users working with challenging clinical, environmental and plant samples.
Jul 22, 2024
-
BOC Sciences is pleased to announce its new Scholarship Program aimed at supporting college students pursuing degrees in chemistry-related fields. This prestigious scholarship awards $1,000 annually to help these aspiring chemists achieve their academic goals and make a difference in the scientific community.
Jul 17, 2024
-
Avallano is launching ProtocolCopilot™, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites manage and interact with complex clinical trial protocols.
Jul 15, 2024
-
Surfix Diagnostics alongside the Netherlands Cancer Institute (NKI) and CRCbioscreen, announced a collaboration aimed at enhancing colorectal cancer (CRC) screening methods.
Jul 9, 2024
-
Synexa Life Sciences has announced its enrolment in the My Green Lab Certification Program.
Jul 9, 2024
-
Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access.
One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new treatments.
Jul 8, 2024
-
Medix Biochemica has announced the appointment of Lonnie Shoff to their Board of Directors.
Jul 7, 2024
-
Jul 3, 2024
-
Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region.
Jul 1, 2024
-
Jun 25, 2024
-
Avallano has ann announced the appointment of Michael A. Ibara, PharmD., as Chief Strategy Officer (CSO).
Jun 25, 2024
-
New KLAS Research report and research study conducted with Quest Diagnostics highlight company’s customer and product momentum
Jun 25, 2024
-
The task force will evaluate AI's use in various aspects of clinical trials, including protocol design, consent considerations, patient privacy and confidentiality, and participant recruitment. It will also evaluate AI when it is being studied as an investigational product for use in medical care.
Jun 25, 2024
-
Partners to host joint conference on ‘Protein Sciences in Drug Discovery’ in Cambridge, UK from 18–19 November 2024
Jun 25, 2024
-
Expanding Proscia’s precision medicine AI pipeline will help to optimize clinical trials and improve treatment decisions
Jun 24, 2024
-
• genesig Easy_oys Detection Kit offers rapid and reliable qPCR workflow to quantify Norovirus GI and GII pathogens in oyster tissue
• Onsite analysis helps ensure shellfish quality and safety across the production line, reducing public health risk
• Developed in collaboration with oyster farmers and Shellfish Association of Great Britain
• Primerdesign to present new developments in Norovirus testing at ACIG: Aquaculture innovation and supply chain resilience (25 June 2024)
Jun 24, 2024
-
AI-powered eClinical Platform, Clinion, announces strategic partnership with eClinical safety solutions provider, Clinevo.
Jun 20, 2024
-
Jun 19, 2024
-
CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations
Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024
Jun 16, 2024
-
Jun 13, 2024